The HER2 flip-HER2 amplification of tumor cells in the cerebrospinal fluid of breast cancer patients with leptomeningeal disease: implications for treating the LM tumor with anti-HER2 therapy

Overview of attention for article published in Frontiers in oncology, May 2024

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (64th percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 8,396 followers.

RT @BrainTumorInst: MBTI's Priya Kumthekar, MD recently led a national study of advanced #CSF analyses of patients with HER2+ #BreastCancer…

RT @BrainTumorInst: MBTI's Priya Kumthekar, MD recently led a national study of advanced #CSF analyses of patients with HER2+ #BreastCancer…

RT @BrainTumorInst: MBTI's Priya Kumthekar, MD recently led a national study of advanced #CSF analyses of patients with HER2+ #BreastCancer…

RT @BrainTumorInst: MBTI's Priya Kumthekar, MD recently led a national study of advanced #CSF analyses of patients with HER2+ #BreastCancer…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.